interstitial lung disease
Information
- Disease name
- interstitial lung disease
- Disease ID
- DOID:3082
- Description
- "A lung disease that is characterized by inflammation and altered lung interstitium compromising pulmonary function and often has_symptom shortness of breath, dyspnea, and/or cough." [url:https\://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215823/]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05716022 | Active, not recruiting | Hiatal Hernia and Pulmonary Involvement | January 5, 2023 | January 2025 | |
| NCT03485378 | Active, not recruiting | N/A | Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung Disease | September 20, 2018 | September 20, 2026 |
| NCT02479126 | Active, not recruiting | Interstitial Lung Diseases in the Veterans Administration | July 2016 | June 2023 | |
| NCT03727568 | Active, not recruiting | N/A | Study Comparing Two Different Methods of Cryobiopsy in the Interstitial Lung Diseases | September 11, 2018 | December 31, 2022 |
| NCT03295279 | Active, not recruiting | WTC Chest CT Imaging Archive | September 1, 2012 | August 2026 | |
| NCT05630599 | Active, not recruiting | Remote Assessment of Lung Disease and Impact on Physical and Mental Health | July 26, 2021 | March 31, 2023 | |
| NCT04136223 | Active, not recruiting | Rheumatoid Arthritis-Associated Interstitial Lung Disease: Characterization of Lung Disease Progression | March 1, 2021 | May 31, 2024 | |
| NCT04227535 | Active, not recruiting | Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Pathogenesis 2 | February 3, 2020 | October 1, 2027 | |
| NCT05068869 | Active, not recruiting | N/A | Digital Outpatient Services | September 12, 2021 | December 31, 2024 |
| NCT04928586 | Active, not recruiting | Phase 4 | Immunosuppressant Combined With Pirfenidone in CTD-ILD | August 16, 2019 | June 1, 2025 |
| NCT03215927 | Active, not recruiting | Phase 2 | Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease | June 1, 2017 | July 30, 2023 |
| NCT04299945 | Active, not recruiting | N/A | Effects of Drinking Beetroot Juice on Exercise Performance in Patients With Fibrotic Interstitial Lung Disease | January 29, 2020 | December 31, 2025 |
| NCT05714787 | Active, not recruiting | Opportunistic Screening for Osteoporotic Vertebral Fractures in Patients With Diffuse Interstitial Lung Disease | January 23, 2017 | June 30, 2023 | |
| NCT04760548 | Active, not recruiting | Segmentation of Structural Abnormalities in Chronic Lung Diseases | January 1, 2008 | February 17, 2024 | |
| NCT05760508 | Active, not recruiting | Novel Markers of Disease Progression in Interstitial Lung Disease | July 23, 2018 | January 2024 | |
| NCT05572996 | Available | Inhaled Treprostinil Expanded Access Program in Pulmonary Hypertension Associated With Interstitial Lung Disease | |||
| NCT01462006 | Completed | N/A | Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF) | October 2011 | March 2016 |
| NCT01570764 | Completed | Phase 3 | Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease | January 14, 2013 | February 22, 2018 |
| NCT01600352 | Completed | Specific Autoantibody Testing in Patients With Interstitial Lung Disease | May 2012 | April 2017 | |
| NCT01713413 | Completed | N/A | Effects of an Oxymizer on Endurance Time in Patients With Chronic Lung Diseases | February 2012 | March 2014 |
| NCT01714518 | Completed | Cryobiopsy vs. VATS in Diagnosis of Interstitial Lung Diseases | October 16, 2012 | June 30, 2017 | |
| NCT01789996 | Completed | N/A | The Six Minute Walk Test: Influence of Instruction on Results | June 2010 | December 2014 |
| NCT01862926 | Completed | Phase 2/Phase 3 | Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD | November 2014 | January 2021 |
| NCT01874223 | Completed | Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF | June 2013 | November 4, 2018 | |
| NCT01894113 | Completed | N/A | Prospective, Randomised Multicenter Study Comparing the Efficacy of Transbronchial Forceps Biopsy With Cryobiopsy to Diagnose Interstitial Lung Disease. | January 2012 | May 2014 |
| NCT01906931 | Completed | Phase 2 | Ambulatory Oxygen for ILD | August 2013 | February 2014 |
| NCT01955824 | Completed | Phase 2/Phase 3 | A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy | May 2014 | November 2014 |
| NCT01972685 | Completed | N/A | Comparison of Transbronchial, Cryoprobe and VATS Biopsy For the Diagnosis of Interstitial Lung Disease (ILD) | June 2013 | March 30, 2018 |
| NCT02019641 | Completed | N/A | The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease | May 23, 2015 | May 24, 2023 |
| NCT02036970 | Completed | Phase 2 | Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT | May 31, 2014 | May 16, 2018 |
| NCT02075762 | Completed | N/A | Comparison of Transbronchial, Cryoprobe, and VATS Biopsy for the Diagnosis of Interstitial Lung Disease | August 2013 | December 2018 |
| NCT02143687 | Completed | Phase 4 | Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise Performance | May 2014 | October 2021 |
| NCT06007040 | Completed | Interstitial Lung Disease Associated | January 2012 | December 2021 | |
| NCT02197364 | Completed | The Role of KL-6 in the Clinical Diagnosis of ILD | December 2013 | May 2014 | |
| NCT02201654 | Completed | N/A | Stylet vs No Stylet During EBUS TBNA | June 2014 | September 2015 |
| NCT05993520 | Completed | Effects of Respiratory Muscle Functions on Interstitial Lung Disease: Sleep Quality, Dyspnea, and Fatigue | June 1, 2020 | June 1, 2023 | |
| NCT02426229 | Completed | Phase 1 | Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma | February 2016 | June 21, 2018 |
| NCT02497144 | Completed | N/A | Neuromuscular Electrical Stimulation in Patients With Interstitial Lung Disease | July 15, 2015 | December 30, 2018 |
| NCT05963048 | Completed | Phase 2/Phase 3 | Rituxmab Versus IL-6 in Treating ILD | December 1, 2021 | June 1, 2023 |
| NCT02594839 | Completed | Phase 1/Phase 2 | Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease | February 2013 | January 2018 |
| NCT02622022 | Completed | Phase 4 | Palliation of Dyspnea With Morphine in Patients With Interstitial Lung Disease | January 2016 | February 6, 2019 |
| NCT02622412 | Completed | N/A | Evaluation of a Multi-professional Breathlessness Service for Patients With Breathlessness Due to Any Advanced Disease | March 2, 2015 | April 30, 2019 |
| NCT02630316 | Completed | Phase 2/Phase 3 | Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE | February 3, 2017 | December 26, 2019 |
| NCT05914909 | Completed | Phase 1 | Safety, Tolerability, PK and PD Study of AD-214 Administered to Healthy Volunteers and Patients With Interstitial Lung Disease or Chronic Kidney Disease | July 17, 2023 | February 9, 2024 |
| NCT02636452 | Completed | Cardiopulmonary Exercise Testing in Interstitial Lung Disease | October 31, 2013 | September 30, 2017 | |
| NCT00362739 | Completed | Blood Collection From Individuals With Lung Disease for Genetic Studies | September 2005 | August 2015 | |
| NCT05784207 | Completed | An In Silico Trial to Evaluate Prospectively the Performance of a Radiomics Algorithm for UIP Compared to Medical Doctors | June 1, 2017 | December 30, 2021 | |
| NCT03729583 | Completed | N/A | The Effects of Breathing Retraining in Patients With Interstitial Lung Diseases | July 1, 2017 | May 18, 2018 |
| NCT04481074 | Completed | N/A | Inspiratory Muscle Training in Patients With Interstitial Lung Disease | July 30, 2020 | April 30, 2021 |
| NCT04503044 | Completed | ILAs in CT Lung Cancer Screening Population | January 30, 2021 | June 30, 2021 | |
| NCT04803617 | Completed | Investigation of Pectoralis Muscle Strength in Elderly With Interstitial Lung Disease | January 23, 2017 | June 23, 2017 | |
| NCT04574050 | Completed | N/A | SELF-BREATHE RCT for Chronic Breathlessness | January 11, 2021 | January 30, 2022 |
| NCT04619680 | Completed | Phase 4 | The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19 | November 18, 2020 | March 1, 2024 |
| NCT00820729 | Completed | Biomarkers in Pulmonary Hypertension Associated to Interstitial Lung Disease | March 2009 | March 2011 | |
| NCT00882817 | Completed | Phase 4 | Pulmonary Rehabilitation in Interstitial Lung Diseases | April 2009 | November 2011 |
| NCT00883129 | Completed | Phase 2 | Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II) | September 2009 | November 2015 |
| NCT00926523 | Completed | Biomarkers in the Evaluation of Chronic Lung Disease | June 2009 | March 2011 | |
| NCT04711057 | Completed | N/A | CENTR(AR): Lungs Moving | April 1, 2021 | December 31, 2023 |
| NCT04715347 | Completed | Interstitial Lung Disease Within a Lung Cancer Screening | November 11, 2017 | June 30, 2020 | |
| NCT01055730 | Completed | The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease | February 2010 | January 2013 | |
| NCT01064609 | Completed | N/A | "Diagnostic Yield and Safety of Transbronchial Lung Biopsy Using Cryoprobes Versus Conventional Forceps. | June 2011 | September 2012 |
| NCT00319033 | Completed | Phase 2/Phase 3 | Open-label Study With Bosentan in Interstitial Lung Disease | July 2004 | February 2006 |
| NCT06260930 | Completed | Value of Chest Ultrasonography in ILD Screening | January 2017 | December 2019 | |
| NCT03416075 | Completed | Mechanical Ventilation in Interstitial Lung Disease | January 1, 2011 | December 31, 2017 | |
| NCT05227443 | Completed | N/A | Effects of Exercise Training on Respiratory Performance in Patients With Fibrosing Interstitial Lung Diseases | January 16, 2020 | July 30, 2021 |
| NCT05095363 | Completed | N/A | Palliative Care Planner (PCplanner) | March 16, 2022 | March 31, 2023 |
| NCT00504361 | Completed | Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar) | May 2006 | May 2012 | |
| NCT03516994 | Completed | N/A | Reducing Disparities in the Quality of Advance Care Planning for Older Adults | August 1, 2018 | April 15, 2024 |
| NCT03599414 | Completed | CASPA: CArdiac Sarcoidosis in PApworth | June 29, 2017 | March 8, 2023 | |
| NCT03641742 | Completed | Families-At-risk for Interstitial Lung Disease Study | January 15, 2018 | July 1, 2023 | |
| NCT04988282 | Completed | Phase 4 | Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease | May 24, 2021 | January 31, 2022 |
| NCT04435327 | Completed | Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19) | October 5, 2020 | March 18, 2022 | |
| NCT04982809 | Completed | N/A | Cost-effectiveness Analysis of Three Corticosteroids in ILDs | July 1, 2018 | March 15, 2020 |
| NCT04946708 | Completed | N/A | Virtual Exercise Program in Interstitial Lung Disease (ILD) Patients | September 1, 2021 | May 17, 2022 |
| NCT00677560 | Completed | The Natural History of Small Airways Physiology in Diseased and Healthy States | June 22, 2010 | July 10, 2013 | |
| NCT00678821 | Completed | Phase 2 | Aerobic Exercise in Patients With Pulmonary Hypertension | June 12, 2008 | September 23, 2015 |
| NCT03929120 | Completed | Phase 1 | Allogeneic Bone Marrow Mesenchymal Stem Cells for Patients With Interstitial Lung Disease (ILD) & Connective Tissue Disorders (CTD) | November 5, 2019 | February 2, 2022 |
| NCT04939558 | Completed | Cardiorespiratory Diagnostic Study | June 2, 2021 | November 30, 2022 | |
| NCT04061356 | Completed | Assessment of Exhaled Breath Condensate Hydrogen Peroxide (EBC H2O2) as Measured Using a New Device (Inflammacheck™) in Patients With Interstitial Lung Disease, Lung Cancer and Healthy Volunteers. | October 30, 2018 | September 14, 2019 | |
| NCT00705133 | Completed | Phase 2 | Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension | July 2008 | April 2011 |
| NCT04138173 | Completed | N/A | Enhancing Physical Activity in Patients With Interstitial Lung Disease | January 14, 2020 | January 6, 2022 |
| NCT04159584 | Completed | N/A | Pilot Study: The Effects of Medical Music on Anxiety in Patients With ILD | April 15, 2019 | September 11, 2019 |
| NCT04184180 | Completed | Effects of Inpatient Pulmonary Rehabilitation on Frailty in Patients After Lung-Transplantation | December 2, 2019 | March 16, 2020 | |
| NCT04879082 | Completed | Identification Of Occupational Exposures In Patients With ILD | May 15, 2020 | April 15, 2021 | |
| NCT04273867 | Completed | Assessing Health Related Quality of Life in Hypersensitivity Pneumonitis | July 10, 2020 | February 22, 2023 | |
| NCT04850521 | Completed | Remote Monitoring of Interstitial Lung Disease | August 3, 2021 | July 7, 2022 | |
| NCT04413149 | Completed | Anti-neutrophil Cytoplasmic Antibody in Interstitial Lung Disease. | April 1, 2014 | April 1, 2020 | |
| NCT04415671 | Completed | Phase 1 | Phase 1 Safety, Tolerability, PK & PD Study of AD-214 Administered to Healthy Volunteers | June 19, 2020 | February 8, 2022 |
| NCT04813900 | Completed | N/A | Correlation Between Lung UltraSound Score and Hypoxemia for Interstitial Syndrome in Emergency Department | April 1, 2021 | August 30, 2021 |
| NCT04430491 | Completed | To Evaluate the Use of Radiomics to Classify Between Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease | January 1, 2005 | July 1, 2017 | |
| NCT02858791 | Completed | MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension | February 2013 | December 21, 2017 | |
| NCT02896205 | Completed | Phase 3 | Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung Disease | October 2016 | July 1, 2017 |
| NCT02934750 | Completed | N/A | Pursed Lip Breathing in Interstitial Lung Disease | October 2016 | January 30, 2017 |
| NCT02988388 | Completed | Lung Tissue Research Consortium | February 23, 2017 | February 21, 2019 | |
| NCT03018756 | Completed | Phase 3 | Nebulized Fentanyl in Patients With Mild to Moderate Interstitial Lung Disease and Chronic Dyspnea | January 2017 | November 30, 2020 |
| NCT03040674 | Completed | An Observational Outcomes Study for Autologous Cell Therapy Among Patients With COPD and Interstitial Lung Disease | January 3, 2017 | December 31, 2020 | |
| NCT03044431 | Completed | Autologous Stem Cell Treatment for Chronic Lung Disease Study | April 1, 2016 | June 9, 2017 | |
| NCT03068091 | Completed | N/A | Assessment of Lung Movement With Computed Tomography (CT) | July 1, 2017 | October 31, 2018 |
| NCT03221257 | Completed | Phase 2 | Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate | November 28, 2017 | June 13, 2022 |
| NCT03261037 | Completed | N/A | A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period | December 25, 2017 | November 27, 2019 |
| NCT00453713 | Completed | Race, Ethnicity, and Diffuse Parenchymal Lung Disease | July 2006 | August 2013 | |
| NCT03300583 | Completed | Toward Self-management in ILD | June 1, 2018 | December 30, 2020 | |
| NCT03302702 | Completed | N/A | Duration of Exercise Program in Interstitial Lung Diseases. | January 2014 | January 2016 |
| NCT03336736 | Completed | The Role of Physical Activity and Diet Within Pulmonary Sarcoidosis | November 7, 2017 | June 15, 2018 | |
| NCT03388580 | Completed | Predictors for Bronchoalveolar Lavage (BAL) Recovery Rate Derived From Quantified Computed Tomography (qCT) | January 2017 | September 2017 | |
| NCT03396120 | Completed | The FVC/DLCO Ratio is a Useful Predictor of Pulmonary Hypertension in Patients With Interstitial Lung Disease | February 2, 2017 | December 31, 2017 | |
| NCT05311345 | Completed | Integration of Cryobiopsies for ILD Diagnoses- Experience Based on 250 Biopsy Procedures. | November 6, 2015 | April 1, 2020 | |
| NCT04896138 | Enrolling by invitation | University of Virginia Natural History Study | August 28, 2018 | August 31, 2035 | |
| NCT04905693 | Enrolling by invitation | Phase 3 | Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis | September 6, 2022 | June 2026 |
| NCT04326036 | Enrolling by invitation | Early Phase 1 | Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection | March 25, 2020 | January 31, 2024 |
| NCT05564637 | Enrolling by invitation | Phase 2 | A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension | March 13, 2023 | June 2024 |
| NCT04016181 | Enrolling by invitation | The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study | June 14, 2007 | December 1, 2036 | |
| NCT05001009 | Enrolling by invitation | N/A | Goals of Care Conversations Study | September 13, 2022 | September 30, 2025 |
| NCT05450276 | Enrolling by invitation | Patient-Reported Outcome Study of Project ECHO for ILD | July 2022 | March 2024 | |
| NCT05609201 | Enrolling by invitation | PRospective Evaluation of Interstitial Lung DIsease Progression With Quantitative CT | June 1, 2023 | October 31, 2024 | |
| NCT04930289 | Enrolling by invitation | Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs | October 15, 2021 | December 30, 2025 | |
| NCT04532346 | Not yet recruiting | Early Phase 1 | Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes | March 2024 | October 2026 |
| NCT06125288 | Not yet recruiting | Risk Factors and Prognostic Parameters of Interstitial Lung Disease in Children | December 2023 | February 2025 | |
| NCT06235645 | Not yet recruiting | dEtection of rheumAtoid aRthritis - Interstitial Lung dIseasE by Thoracic ultRasound | March 2024 | September 2026 | |
| NCT03800017 | Not yet recruiting | N/A | Skeletal Muscle Function in Interstitial Lung Disease | June 1, 2024 | December 31, 2026 |
| NCT06388421 | Not yet recruiting | DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) | August 1, 2024 | November 30, 2030 | |
| NCT04897048 | Not yet recruiting | N/A | Effect of Short-term Oxygen During CPET in ILD | July 1, 2023 | December 1, 2024 |
| NCT03870828 | Not yet recruiting | Clinical Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF) - a Multicenter Prospective Study | March 18, 2019 | December 31, 2025 | |
| NCT06325696 | Not yet recruiting | Phase 2 | H01 in Adults With Interstitial Lung Disease (The SOLIS Study) | June 23, 2024 | December 31, 2025 |
| NCT05785065 | Not yet recruiting | Phase 2 | Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease | December 2023 | December 2026 |
| NCT04719078 | Not yet recruiting | N/A | Thorax MRI for Evaluation of Lung Morphology, Ventilation and Perfusion | June 1, 2023 | December 31, 2023 |
| NCT05947422 | Not yet recruiting | CT Quantitative Assessment of Interstitial Lung Disease | August 1, 2023 | October 1, 2024 | |
| NCT06326957 | Not yet recruiting | N/A | Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention (SELF-BREATHE) | May 2024 | July 2028 |
| NCT06174207 | Not yet recruiting | N/A | Hyperoxia During Pulmonary Rehabilitation in Chronic Lung Disease - Does it Matter? | January 1, 2024 | April 30, 2025 |
| NCT06182956 | Not yet recruiting | N/A | NIV Versus HFO for Acute Exacerbations of Interstitial Lung Diseases | January 1, 2024 | December 31, 2026 |
| NCT06416163 | Not yet recruiting | FIBRotic Interstitial Lung Disease With Nocturnal hypOXaemia and EXercise Induced desaTuRAtion | July 1, 2024 | July 1, 2029 | |
| NCT06297096 | Not yet recruiting | Phase 3 | Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease | April 1, 2024 | March 30, 2028 |
| NCT05986318 | Not yet recruiting | Phase 2 | Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease | May 1, 2024 | December 31, 2032 |
| NCT05999838 | Not yet recruiting | HR Chest CT Visual Scoring, Spirometry and Health Related Quality of Life in Evaluating Severity of ILD Patients | October 2023 | February 2025 | |
| NCT06447831 | Recruiting | Assessing Functional Capacity in Directly and Remotely Monitored Home-based Settings: A Protocol for a Multinational Validation Study in Individuals With Chronic Respiratory Diseases | February 2, 2024 | January 2026 | |
| NCT01280994 | Recruiting | Phase 2 | Hyperpolarized 129Xe MRI for Imaging Pulmonary Function | January 2011 | December 2025 |
| NCT02748798 | Recruiting | Early Phase 1 | Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders | November 10, 2020 | December 22, 2023 |
| NCT03297775 | Recruiting | Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease | June 22, 2017 | June 2027 | |
| NCT03478826 | Recruiting | Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD) | August 1, 2018 | January 2028 | |
| NCT03630211 | Recruiting | Phase 2 | Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis | July 31, 2018 | August 1, 2025 |
| NCT03814317 | Recruiting | Phase 2 | Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension | January 30, 2020 | July 29, 2025 |
| NCT03901196 | Recruiting | Multi-elemental Imaging of Lung Tissues With LIBS (Laser-induced Breakdown Spectroscopy) | January 22, 2020 | January 22, 2025 | |
| NCT03901534 | Recruiting | N/A | Assessment of Continuous Positive Airway Pressure Therapy in IPF | January 1, 2023 | December 31, 2025 |
| NCT04095351 | Recruiting | Connective Tissue Diseases and Lung Manifestations | December 9, 2019 | October 1, 2034 | |
| NCT04328181 | Recruiting | N/A | Comparison of Imaging Quality Between Spectral Photon Counting Computed Tomography (SPCCT) and Dual Energy Computed Tomography (DECT) | January 29, 2021 | January 29, 2026 |
| NCT04624490 | Recruiting | Phase 1 | Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease | November 2, 2020 | October 26, 2026 |
| NCT04664192 | Recruiting | Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research | June 4, 2021 | December 1, 2026 | |
| NCT04676594 | Recruiting | Genentech Validation Tool for Pulmonary Fibrosis | October 4, 2020 | October 30, 2024 | |
| NCT04708782 | Recruiting | Phase 3 | Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis | June 1, 2021 | June 2025 |
| NCT04778046 | Recruiting | Phase 2 | Pulmonary Hypertension SOLAR | November 8, 2023 | December 30, 2024 |
| NCT04925375 | Recruiting | Phase 2 | Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease | July 14, 2021 | July 2025 |
| NCT05007340 | Recruiting | ILD-SARDs Registry and Biorepository | August 24, 2021 | August 2026 | |
| NCT05120934 | Recruiting | Phase 2 | Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough | November 1, 2021 | December 2025 |
| NCT05177471 | Recruiting | Efficacy and Safety of JAK Inhibitors in Systemic Sclerosis-associated Interstitial Lung Disease | January 19, 2022 | July 4, 2024 | |
| NCT05246293 | Recruiting | Phase 2 | Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease. | August 8, 2022 | March 2, 2025 |
| NCT05255991 | Recruiting | Phase 3 | Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis | October 4, 2022 | June 2025 |
| NCT05270668 | Recruiting | Phase 2 | Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007) | July 13, 2022 | December 30, 2028 |
| NCT05345795 | Recruiting | Interstitial Lung Disease Trajectories in Patients With Systemic Sclerosis | May 1, 2023 | September 1, 2024 | |
| NCT05365802 | Recruiting | Early Phase 1 | FAPI PET for Lung Fibrosis | November 16, 2021 | December 2026 |
| NCT05372926 | Recruiting | N/A | Physiological Effects of HFNC During Exercise in Patients With Fibrosing Interstitial Lung Diseases | November 22, 2022 | November 23, 2024 |
| NCT05375435 | Recruiting | Phase 4 | Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive Dermatomyositis | January 1, 2022 | December 31, 2024 |
| NCT05382572 | Recruiting | Pulmonary Fibrosis Foundation Community Registry | July 11, 2022 | July 1, 2025 | |
| NCT05391100 | Recruiting | Screening of Patients With Rheumatoid Arthritis for Interstitial Lung Disease | February 1, 2022 | December 2026 | |
| NCT05392881 | Recruiting | Interstitial Lung Disease Research Unit Biobank | August 9, 2021 | March 1, 2032 | |
| NCT05417776 | Recruiting | Phase 2 | Collagen-targeted PET Imaging for Early Interstitial Lung Disease | September 28, 2022 | April 1, 2024 |
| NCT05445817 | Recruiting | Pulmonary Care and Research Collaborative Patient Registry | July 2022 | March 2024 | |
| NCT05482607 | Recruiting | Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease | January 1, 2023 | October 1, 2024 | |
| NCT05505409 | Recruiting | Phase 4 | Efficacy and Safety of Pirfenidone in CTD-ILD | June 22, 2022 | December 1, 2025 |
| NCT05514522 | Recruiting | The UK Interstitial Lung Disease Long-COVID19 Study (UKILD-Long COVID): Understanding the Burden of Interstitial Lung Disease in Long COVID. | August 18, 2021 | March 31, 2024 | |
| NCT05631132 | Recruiting | N/A | May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases? | September 4, 2022 | June 1, 2024 |
| NCT05631756 | Recruiting | N/A | Correlation Between PaO2/FiO2 and Lung Ultrasound Score in the Intensive Care Unit | January 26, 2023 | December 30, 2024 |
| NCT05646407 | Recruiting | N/A | Move With Air: Exercise Training Study | April 1, 2023 | March 30, 2025 |
| NCT05649722 | Recruiting | Phase 2/Phase 3 | An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) | May 11, 2023 | May 31, 2024 |
| NCT05659550 | Recruiting | N/A | Move With Air: Physiological Response Assessment | April 1, 2023 | December 30, 2024 |
| NCT05662124 | Recruiting | N/A | ILD: Health Outcomes in Remote Digital Monitoring Versus Usual Care | March 7, 2023 | April 2025 |
| NCT05681962 | Recruiting | Practice of Oxygenation and Respiratory Support During Fiberoptic Bronchoscopy | February 15, 2023 | April 30, 2024 | |
| NCT05746039 | Recruiting | Phase 1/Phase 2 | Feasibility of Semaglutide in Advanced Lung Disease | January 29, 2024 | June 28, 2024 |
| NCT05776225 | Recruiting | Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection | August 11, 2023 | February 1, 2025 | |
| NCT05810493 | Recruiting | A Cohort of Patients With Phenotyped Diffuse Interstitial Lung Disease With Longitudinal Follow-up | January 1, 2022 | December 31, 2025 | |
| NCT05824910 | Recruiting | N/A | Effect of Pulmonary Telerehabilitation and Telemonitoring for Patients With Chronic Respiratory Diseases | May 20, 2024 | December 30, 2024 |
| NCT05827302 | Recruiting | N/A | Integrating ePReBMs From Phoenix in Respiratory Diseases | October 11, 2023 | April 2028 |
| NCT05830318 | Recruiting | Usability and Acceptability Study of the P-STEP Mobile Application | August 23, 2023 | January 31, 2024 | |
| NCT05892614 | Recruiting | Phase 2 | Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD) | October 26, 2023 | December 2024 |
| NCT05894148 | Recruiting | Phase 1 | Clinical Study of Multiple Dose Genakumab for Injection in Chinese Healthy Adults | March 6, 2023 | November 30, 2023 |
| NCT05895409 | Recruiting | A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis | July 27, 2023 | June 1, 2028 | |
| NCT05916404 | Recruiting | N/A | Effects of Upper Extremity Aerobic Exercise Training in Patients With Interstitial Lung Disease | July 3, 2023 | June 1, 2025 |
| NCT05943535 | Recruiting | Phase 3 | Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) | October 30, 2023 | November 2027 |
| NCT05998512 | Recruiting | Integrating Molecular, Genomic, Morphology and Environmental Features to Improve Precision Diagnosis and Treatment in Interstitial Lung Diseases (PRECISION-ILD) | July 10, 2023 | December 31, 2025 | |
| NCT06016959 | Recruiting | N/A | Specialist Dietetic Intervention in Malnourished Patients With Fibrotic ILD: a Randomised Controlled Pilot Trial | June 20, 2023 | March 1, 2024 |
| NCT06027333 | Recruiting | Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease | November 8, 2023 | August 30, 2024 | |
| NCT06038630 | Recruiting | Phase 2 | 129Xe MRI Cardiopulmonary | January 12, 2024 | June 30, 2028 |
| NCT06046547 | Recruiting | N/A | Integrating Palliative Care Education in Pulmonary Rehabilitation | September 1, 2023 | June 2026 |
| NCT06066658 | Recruiting | N/A | Anxiety Management in Breathlessness. | October 2023 | June 2024 |
| NCT06068647 | Recruiting | N/A | Ultrasound and Respiratory Physiological Signals in Lung Diseases | March 22, 2023 | March 31, 2025 |
| NCT06087692 | Recruiting | N/A | Efficacy of Video-Based Interactive Game Therapy in Interstitial Lung Patients | January 1, 2023 | March 1, 2024 |
| NCT06090149 | Recruiting | N/A | Telemedical Assistance in Automatic Titration of Oxygen for Intensive Care Patients | March 1, 2023 | November 30, 2023 |
| NCT06129240 | Recruiting | An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH | December 28, 2023 | October 31, 2026 | |
| NCT06133998 | Recruiting | N/A | Effects of Incentive Spirometry With and Without Aerobic Exercises in Interstitial Lung Disease | September 20, 2023 | December 10, 2023 |
| NCT06141603 | Recruiting | Comparison of Upper and Lower Limb Maximal Exercise Capacities and Muscle Oxygenation in Patients With ILD | November 25, 2023 | December 30, 2024 | |
| NCT06143540 | Recruiting | Clinical Study of 18F-FAPI-RGD in Interstitial Lung Disease Associated With Connective Tissue Disease | August 16, 2023 | July 2024 | |
| NCT06247397 | Recruiting | N/A | Effect of HIgh-flow Therapy in Long-term Oxygen Therapy | June 10, 2024 | December 2028 |
| NCT06397677 | Recruiting | Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease | January 22, 2024 | January 2034 | |
| NCT04843345 | Suspended | Sjogren's Lung Study | April 1, 2021 | April 1, 2030 | |
| NCT02615938 | Suspended | Phase 2 | Hydroxychloroquin (HCQ) in Pediatric Interstitial Lung Disease (ILD) | April 2015 | April 2025 |
| NCT04036721 | Suspended | Phase 4 | Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis | October 1, 2019 | February 1, 2026 |
| NCT01203943 | Terminated | Phase 2 | A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF) | January 1, 2011 | August 24, 2012 |
| NCT01424033 | Terminated | Phase 2/Phase 3 | A Clinical Trial for CTD-ILD Treatment | December 2011 | |
| NCT00744614 | Terminated | Use Of Capnography As Surrogate Measure Of PC02 In Medical Intensive Care Unit (ICU) Patients | November 2007 | October 2010 | |
| NCT01381666 | Terminated | Phase 2 | Evaluation of the Diagnostic Utility of INS316 in Patients With Interstitial Lung Diseases (01-701) | January 2003 | April 2004 |
| NCT02633293 | Terminated | Phase 2/Phase 3 | An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE | September 15, 2016 | August 1, 2021 |
| NCT04837131 | Terminated | Phase 2 | A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients | April 28, 2021 | February 23, 2024 |
| NCT05079126 | Terminated | Phase 2 | Study of Trans Sodium Crocetinate in Patients With Interstitial Lung Disease | December 2, 2021 | May 27, 2022 |
| NCT02958917 | Terminated | Phase 2 | Study of Efficacy and Safety of Pirfenidone in Patients With Fibrotic Hypersensitivity Pneumonitis | June 5, 2017 | March 2, 2021 |
| NCT02813447 | Terminated | N/A | Safety of Anti-Depressant for Chronic Obstructive Pulmonary Disease (SAD-COPD) | August 2016 | February 20, 2019 |
| NCT05267418 | Terminated | N/A | Effects of Automated Oxygen Titration Alone or With High Flow Nasal Therapy on Dyspnea and Exercise Tolerance | February 26, 2019 | March 30, 2021 |
| NCT01559129 | Terminated | Phase 2 | Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease | August 9, 2012 | November 3, 2016 |
| NCT03958162 | Unknown status | N/A | The Comparison of Uniportal and Tubeless Video Assisted Thoracic Surgery and Transbronchial Lung Cryobiopsy in the Diagnosis of Interstitial Lung Disease | June 1, 2019 | June 1, 2020 |
| NCT03824834 | Unknown status | Phase 2 | Morphine to Maximize the Benefits of Exercise Training in COPD or ILD and Persistent Breathlessness | August 6, 2019 | November 2020 |
| NCT03770663 | Unknown status | Phase 3 | Cyclophosphamide and Azathioprine vs Tacrolimus in Antisynthetase Syndrome-related Interstitial Lung Disease | February 5, 2021 | January 2, 2024 |
| NCT03726398 | Unknown status | Phase 2/Phase 3 | CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH | September 1, 2018 | December 1, 2020 |
| NCT03670576 | Unknown status | It's Not JUST Idiopathic Pulmonary Fibrosis Study | November 11, 2018 | November 11, 2022 | |
| NCT03560154 | Unknown status | N/A | Effects of Whole Body Vibration Training in Patients With Interstitial Lung Disease | January 2017 | September 2020 |
| NCT03467880 | Unknown status | Multicenter Study of Impulse Oscillometry in Chinese | September 2016 | December 2018 | |
| NCT05106556 | Unknown status | N/A | Effect of Respiratory Muscle Training in Interstitial Lung Patients | December 9, 2019 | January 31, 2022 |
| NCT05129410 | Unknown status | Phase 4 | Clinical Study of MMF in Treatment of IIM-ILD and Its Effect on Peripheral Blood Treg Cells | December 1, 2020 | November 30, 2023 |
| NCT02827734 | Unknown status | Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD) | October 2015 | December 2020 | |
| NCT03440489 | Unknown status | N/A | Assessment of Skeletal Muscle Dysfunction in Patient With Idiopathic Pulmonary Fibrosis | July 2018 | July 2020 |
| NCT02826265 | Unknown status | Evaluation of Novel Lung Function Parameters and Quantitative Computed Tomography (qCT) in Patients With Pulmonary Disease | January 2016 | December 2020 | |
| NCT02150616 | Unknown status | Phase 4 | Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Breathing and Sleep | May 2014 | December 2020 |
| NCT02824757 | Unknown status | The Effects of Glucocorticoids on Glucose Metabolism in Patients With Interstitial Lung Disease | March 2016 | March 2017 | |
| NCT03400839 | Unknown status | Best Clinical Endpoints That Likely Induce Worse Prognosis in Interstitial Lung Diseases | September 15, 2017 | October 1, 2023 | |
| NCT05335278 | Unknown status | N/A | Tolerability and Safety of Nintedanib in Myositis Associated Interstitial Lung Disease: a Pilot Study | June 1, 2021 | May 31, 2023 |
| NCT00637065 | Unknown status | Phase 4 | Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study | April 2008 | August 2010 |
| NCT02821689 | Unknown status | Phase 4 | Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis | July 2016 | June 2018 |
| NCT00168285 | Unknown status | N/A | Pulmonary Rehabilitation in Interstitial Lung Disease | March 2005 | May 2007 |
| NCT01809574 | Unknown status | The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease | May 2013 | March 2016 | |
| NCT01711151 | Unknown status | Interstitial Lung Disease Questionnaire | November 2012 | November 2013 | |
| NCT03238989 | Unknown status | Interstitial Lung Disease Registry Construction | January 5, 2014 | December 31, 2023 | |
| NCT02136394 | Unknown status | The Role of Gastroesophageal Reflux in Scleroderma Pulmonary Fibrosis | February 2014 | April 2017 | |
| NCT03099525 | Unknown status | Treatment Outcome and Prognostic Factors for Rheumatoid Arthritis (RA) Patients With Interstitial Lung Disease (ILD) | October 2016 | March 2022 | |
| NCT03084419 | Unknown status | Phase 2 | APRIL (AbatacePt in Rheumatoid Arthritis-ILD) | June 26, 2018 | March 1, 2020 |
| NCT02885961 | Unknown status | N/A | The Coagulation Cascade in Idiopathic Pulmonary Fibrosis | August 2016 | |
| NCT02235779 | Unknown status | N/A | Diagnostic Yield of Transbronchial Cryobiopsy in Diagnosis of Interstitial Lung Diseases | August 2014 | December 2021 |
| NCT02579304 | Unknown status | Diagnostic Value of Transbronchial Lung Cryobiopsy | January 2019 | June 2023 | |
| NCT04624191 | Unknown status | N/A | Clinical Impact of HOME Oxygen SATURation Measurement (SATURHOME) | November 11, 2020 | June 30, 2023 |
| NCT02563730 | Unknown status | N/A | Open Label Trial of Utility of Cryobiopsy in the Multidisciplinary Diagnosis of Idiopathic Interstitial Lung Disease | November 2014 | |
| NCT04544722 | Unknown status | N/A | Clinical Study of Jianfei Kangfu Cao in the Treatment of pSS-ILD | October 1, 2020 | June 1, 2023 |
| NCT04805086 | Unknown status | Phase 1/Phase 2 | The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19 | March 8, 2021 | March 5, 2023 |
| NCT04428957 | Unknown status | N/A | Telemonitoring of Treatment Effects in Connective Tissue Disease-associated Interstitial Lung Disease (TEL-CTD-ILD) | February 11, 2020 | April 2022 |
| NCT04331548 | Unknown status | Endobronchial Ultrasound Transbronchial Needle Aspiration Of Enlarged Mediastinal In Interstitial Lung Disease | May 30, 2020 | January 30, 2024 | |
| NCT04193592 | Unknown status | Phase 2 | Efficacy and Safety of Pirfenidone Treatment in HPS-ILD | December 1, 2019 | December 31, 2022 |
| NCT04139356 | Unknown status | N/A | The Effect of Spontaneous Respiration on Pulse-oximetry Measurements | September 1, 2019 | December 15, 2019 |
| NCT04098094 | Unknown status | Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases | September 19, 2019 | October 30, 2022 | |
| NCT04089826 | Unknown status | Long Term Oxygen Therapy in Patients With Interstitial Lung Disease | September 2019 | October 2020 | |
| NCT02278107 | Unknown status | N/A | Evaluation of a Lightweight Nasal Interface and Ventilator in Patients With Respiratory Disease | July 2014 | December 2016 |
| NCT03977415 | Unknown status | Interstitial Lung Disease in Early Rheumatoid Arthritis | March 27, 2018 | August 1, 2021 | |
| NCT00625079 | Withdrawn | Phase 4 | Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil | February 2007 | December 2009 |
- Disase is a (Disease Ontology)
- DOID:850
- Cross Reference ID (Disease Ontology)
- GARD:13336
- Cross Reference ID (Disease Ontology)
- ICD10CM:J84.9
- Cross Reference ID (Disease Ontology)
- MESH:D017563
- Cross Reference ID (Disease Ontology)
- MIM:PS619611
- Cross Reference ID (Disease Ontology)
- NCI:C164315
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:64667001
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0206062
- Exact Synonym (Disease Ontology)
- ILD